An adaptive, double-Blind, randomized, placebo-Controlled phase I clinical study to evaluate the the safety, tolerability, pharmacokinetics, and pharmacological effect of orally administered CORT-125134

Trial Profile

An adaptive, double-Blind, randomized, placebo-Controlled phase I clinical study to evaluate the the safety, tolerability, pharmacokinetics, and pharmacological effect of orally administered CORT-125134

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Oct 2017

At a glance

  • Drugs Relacorilant (Primary)
  • Indications Alcoholism; Cushing syndrome; Solid tumours
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 20 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top